Humans Affected by Same Malaria Parasite as Monkeys
|
By LabMedica International staff writers Posted on 07 Oct 2015 |
![Image: Photomicrograph of a band-form trophozoite of P. malariae in a thin blood smear (Photo courtesy of the CDC – [US] Centers of Disease Control and Prevention). Image: Photomicrograph of a band-form trophozoite of P. malariae in a thin blood smear (Photo courtesy of the CDC – [US] Centers of Disease Control and Prevention).](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2015-10-07/RLJ-324.jpg)
Image: Photomicrograph of a band-form trophozoite of P. malariae in a thin blood smear (Photo courtesy of the CDC – [US] Centers of Disease Control and Prevention).
The quartan malaria parasite Plasmodium malariae is the widest spread and best adapted human malaria parasite while the simian P. brasilianum causes quartan fever in New World monkeys and resembles P. malariae morphologically.
Malaria parasites of the Plasmodium brasilianum species have been discovered in the Yanomami, an indigenous people on the border between Venezuela and Brazil, and this malaria species had only been found in monkeys in the past.
Tropical medicine experts at the University of Tübingen (Germany) and their colleagues took thick and thin blood smears from individuals who presented with a history of fever and/or headache and/or malaise. Blood samples were collected by finger prick and stored on filter papers. 633 samples were used for the retrospective screening to investigate the molecular genetics of P. malariae parasites. Parasite DNA from field samples was extracted from dried blood spots on filter paper using a commercial extraction kit, the QIAamp DNA Blood Mini Kit, (Qiagen; Venlo, Netherlands).
Screening for Plasmodium spp. infection was carried out by conventional nested-polymerase chain reaction (PCR) assay with genus and species specific primers based on is sensitive and typically employed in the differential diagnosis of species, the 145 bp product of this primer set is too short for extensive sequence analysis. Therefore, the team designed new sequencing primers targeting an amplicon spanning the entire variable region 5 (V5), one of the eight highly variable regions in the 18S gene which has considerable sequence variations among Plasmodium species.
The determination of malaria by conventional nested-PCR detected the presence of P. malariae DNA in 75 of 633 samples collected from different individuals in Yanomami villages, constituting an 11.8% carrier rate. Out of the 75 samples PCR-positive for P. malariae, the 18S gene from 33 samples (27 mono-infections and six mixed infections) was successfully amplified and the resulting 763 bp product was analyzed by sequencing. Based on 18S rRNA gene sequencing, the scientists identified 12 patients harboring malaria parasites which were 100% identical with P. brasilianum isolated from the red howler monkey, Alouatta seniculus. Translated amino acid sequences of the circumsporozoite protein (CSP) gene showed identical immunodominant repeat units between quartan malaria parasites isolated from both humans and monkeys.
The authors concluded that as quartan parasites are the only global human malaria parasites successfully infecting multiple mammalian hosts, they could evade control measures that do not account for the animal reservoir. These hidden and possibly emerging parasites could, therefore, represent an important area for future investigations. Recently P. knowlesi, another monkey parasite has found to naturally infect humans. The study was published on September 25, 2015, in the specialist journal EbioMedicine.
Related Links:
University of Tübingen
Qiagen
Malaria parasites of the Plasmodium brasilianum species have been discovered in the Yanomami, an indigenous people on the border between Venezuela and Brazil, and this malaria species had only been found in monkeys in the past.
Tropical medicine experts at the University of Tübingen (Germany) and their colleagues took thick and thin blood smears from individuals who presented with a history of fever and/or headache and/or malaise. Blood samples were collected by finger prick and stored on filter papers. 633 samples were used for the retrospective screening to investigate the molecular genetics of P. malariae parasites. Parasite DNA from field samples was extracted from dried blood spots on filter paper using a commercial extraction kit, the QIAamp DNA Blood Mini Kit, (Qiagen; Venlo, Netherlands).
Screening for Plasmodium spp. infection was carried out by conventional nested-polymerase chain reaction (PCR) assay with genus and species specific primers based on is sensitive and typically employed in the differential diagnosis of species, the 145 bp product of this primer set is too short for extensive sequence analysis. Therefore, the team designed new sequencing primers targeting an amplicon spanning the entire variable region 5 (V5), one of the eight highly variable regions in the 18S gene which has considerable sequence variations among Plasmodium species.
The determination of malaria by conventional nested-PCR detected the presence of P. malariae DNA in 75 of 633 samples collected from different individuals in Yanomami villages, constituting an 11.8% carrier rate. Out of the 75 samples PCR-positive for P. malariae, the 18S gene from 33 samples (27 mono-infections and six mixed infections) was successfully amplified and the resulting 763 bp product was analyzed by sequencing. Based on 18S rRNA gene sequencing, the scientists identified 12 patients harboring malaria parasites which were 100% identical with P. brasilianum isolated from the red howler monkey, Alouatta seniculus. Translated amino acid sequences of the circumsporozoite protein (CSP) gene showed identical immunodominant repeat units between quartan malaria parasites isolated from both humans and monkeys.
The authors concluded that as quartan parasites are the only global human malaria parasites successfully infecting multiple mammalian hosts, they could evade control measures that do not account for the animal reservoir. These hidden and possibly emerging parasites could, therefore, represent an important area for future investigations. Recently P. knowlesi, another monkey parasite has found to naturally infect humans. The study was published on September 25, 2015, in the specialist journal EbioMedicine.
Related Links:
University of Tübingen
Qiagen
Latest Molecular Diagnostics News
- Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
- Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
- Two-in-One DNA Analysis Improves Diagnostic Accuracy While Saving Time and Costs
- “Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
- New Tool Maps Chromosome Shifts in Cancer Cells to Predict Tumor Evolution
- Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
- Newly-Identified Parkinson’s Biomarkers to Enable Early Diagnosis Via Blood Tests
- New Blood Test Could Detect Pancreatic Cancer at More Treatable Stage
- Liquid Biopsy Could Replace Surgical Biopsy for Diagnosing Primary Central Nervous Lymphoma
- New Tool Reveals Hidden Metabolic Weakness in Blood Cancers
- World's First Blood Test Distinguishes Between Benign and Cancerous Lung Nodules
- Rapid Test Uses Mobile Phone to Identify Severe Imported Malaria Within Minutes
- Gut Microbiome Signatures Predict Long-Term Outcomes in Acute Pancreatitis
- Blood Test Promises Faster Answers for Deadly Fungal Infections
- Blood Test Could Detect Infection Exposure History
- Urine-Based MRD Test Tracks Response to Bladder Cancer Surgery
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more







